Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for RESTASIS
- Topical Cyclosporin A 0.05% Eye Drops for Management of Symptomatic Acquired Punctal Stenosis. A Prospective, Controlled Clinical Study.
- HU007 in Patients With Dry Eye Syndrome
- A Feasibility Study to Evaluate the Tolerability of Oph1 Compared to Restasis in Healthy Volunteers
- Novel Use of Cyclosporine Ophthalmic Emulsion 0.05% on Application of PROSE Devices for Management of Patients With Ocular Surface Disease
- Prospective, Randomized, Masked, Controlled Trial To Evaluate The Safety And Effectiveness Of The TearCare® System In The Treatment Of The Signs And Symptoms Of Dry Eye Disease (SAHARA)
- Novel Use of Restasis and PROSE Devices
- A Research Study To See How Well an Eye Drop, SURF-100 (A Mycophenolic Acid/Betamethasone Sodium Phosphate Combination), Works and What Side Effects There Are in Subjects With Dry Eye Disease
- Comparing Treatment of Dry Eye With Intracanlicular Dexamethasone, Restasis, and/or Lotemax
- HU007 Eye Drops in Patients With Dry Eye Syndrome
- Comparing Effect of Topical Tacrolimus 0.03% Versus Cyclosporine 0.05% in Dry Eyes of Secondary Sjogren Syndrome
- Autologous Plasma Treatment for Severe Dry Eye Patients
- Ocular Tolerability of Voclosporin Ophthalmic Solution Versus Restasis® in Subjects With Dry Eye Disease
- Efficacy and Safety of HU007 Eye Drops in Patients With Dry Eye Syndrome
- Corneal Tear Film Imaging of the Cornea Before and After Restasis Therapy
- Efficacy and Safety Study of HU00701/HU007 Eye Drops in Patients With Dry Eye Syndrome
- CyclASol for the Treatment of Moderate to Severe Dry-eye Disease (DED)
- Evaluation of Maintaining Visual Performance in Participants Who Engage in Electronic Visual Tasking While Using Restasis®
- Efficacy and Safety of HE10 for Dry Eye Syndrome
- Efficacy and Safety Study of TJCS for Treatment of Moderate to Severe Dry Eye Syndromes
- Study of Tisporin Eye Drops Group and Restasis Eye Drops Group After Treatment, Each Treatment Group Comparisons for Evaluation of Efficacy and Safety in Moderate to Severe Dry Eye Disease
- The Effects of Cyclosporin A in a Low Humidity Environment, on the Ocular Surface
- Investigation of Maintaining Visual Performance Achieved With Cyclosporine Therapy
- A Phase IV, Randomized, Parallel Group, Investigator-Masked Evaluation of the Effect of Loteprednol Etabonate Ophthalmic Gel 0.5% on the Initiation of Dry Eye Treatment With Restasis®
- Phase 2 Study of a New Ophthalmic Formulation of Cyclosporine (Restasis® X) in Patients With Dry Eye Disease
- Safety Study of the Use of Topical Cyclosporine in the Treatment of Dry Eye Disease
- Lotemax® Gel 0.5% and Restasis 0.05% in Participants With Mild or Moderate Keratoconjunctivitis Sicca (Dry Eye Disease)
- Efficacy and Safety Study of Haporine-S for Treatment of Moderate to Severe Dry Eye Syndromes
- Study of Cyclosporine Ophthalmic Soution Group and Cyclosporine Ophthalmic Suspension Group
- Identification and Validation of Functional Biomarkers for Keratoconus
- Treatment of Ocular Graft-versus-Host Disease (GVHD) With Topical Loteprednol Etabonate 0.5%
- Efficacy of 0.05% Cyclosporin Eye Drop in Stevens Johnson Syndrome Patient With Chronic Dry Eye
- Study of Two Formulations of Cyclosporine Ophthalmic Emulsion in Healthy Volunteers and in Patients With Dry Eye
- Safety and Efficacy of Cyclosporine Ophthalmic Emulsion in Patients With Primary Pterygium
- Pilot Study of a Homeopathic Therapy in Combination With Cyclosporin (Restasis) in the Treatment of Dry Eye Disease
- Topical Cyclosporine Suspension for the Treatment of Brittle Nails
- Long-term Topical Cyclosporine for Atopic Keratoconjunctivitis
- Restasis for Treatment of Brittle Nails
- Topical Cyclosporine vs. Placebo for Epiphora Associated With Docetaxel
- Cyclosporine Eye Drops in Preventing Graft-Versus-Host Disease of the Eye in Patients Who Have Undergone Donor Stem Cell Transplant for Hematologic Cancer or Bone Marrow Failure Disorder
- Efficacy of 0.05 % Cyclosporine Ophthalmic Emulsion Compare With Tear in Meibomian Gland Dysfunction
- Topical Cyclosporine and Disease Progression
- Objective Measurements of Prolonged Effects of Restasis on Dry Eye Disease
- Evaluation of Blink Tears and Systane Concomitant With Restasis for the Treatment of Dry Eye Symptoms
- The Prophylactic Use of Topical Cyclosporine A 0.05% to Prevent Graft Versus Host Disease Related Dry Eye
- Oasys vs. Extreme H20 Xtra 59
- Multicenter, Randomized, Controlled Study of the Effect of Lotemax on Initiation of Dry Eye Treatment With Restasis
- Efficacy and Safety of a New Multi-dose Lubricant Eye Drop Concomitant With Restasis® (Cyclosporine A) for the Treatment of Dry Eye Symptoms
- Will Restasis Eye Drops Increase Your Chance of Having a Successful Surgery?
- Efficacy of Optive Versus Systane Concomitant With Restasis (Cyclosporine A) for the Treatment of Dry Eye Symptoms
- Efficacy of Cyclosporine for the Prevention and Treatment of Dry Eye Symptoms Following LASIK or Photorefractive Keratectomy
- Efficacy of Topical Cyclosporin for Ocular Rosacea
Clinical trials list
click for details